logo
Plus   Neg
Share
Email

Black Knight Q2 Profit Tops Estimates; Expects FY Adj. EPS At Low End Of Outlook

Black Knight, Inc. (BKI) reported that its second-quarter adjusted earnings per share increased 7 percent to $0.49 from $0.46, prior year. On average, 14 analysts polled by Thomson Reuters expected the company to report profit per share of $0.48, for the quarter. Analysts' estimates typically exclude special items.

Second-quarter adjusted revenues increased 6 percent to $295.1 million compared to $277.4 million, last year. Analysts expected revenue of $296.19 million for the quarter.

For the full year, the company now expects adjusted earnings per share to be at the low end of the prior guidance range of $1.90 to $2.00. Revenues are expected to be at the low end of the prior guidance range of $1.18 billion to $1.20 billion. Analysts polled by Thomson Reuters expect the company to report profit per share of $1.97 on revenue of $1.19 billion.

Black Knight CEO Anthony Jabbour said: "While our performance through the first half of the year was in line with our expectations, we have updated our full year 2019 outlook to reflect an earlier than planned client deconversion that was the result of a decision we made to no longer support a non-core, single-client platform."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Video streaming giant Netflix said it will donate 1 million euros to Audiens, the social protection group of the French cultural sector, to help launch a COVID-19 emergency relief fund to support workers in the French television and cinema industry. Netflix and Audiens said they have created the new COVID-19 Film and TV Emergency Relief Fund to help the hardest hit workers in the industry. Major U.S. retail container ports are estimated to report a five-year low for imports in March as consumer demand has been impacted with millions of Americans out of work amid the coronavirus (COVID-19) outbreak, according to a report by the National Retail Federation or NRF. The U.S. Food and Drug Administration has issued warning letters to three sellers of fraudulent COVID-19 products. There are currently no approved preventatives or treatments for COVID-19, the FDA said in a statement.
RELATED NEWS
Follow RTT
>